Identifying significant genes and functionally enriched pathways in familial hypercholesterolemia using integrated gene co-expression network analysis
- PMID: 35844366
- PMCID: PMC9280244
- DOI: 10.1016/j.sjbs.2022.02.002
Identifying significant genes and functionally enriched pathways in familial hypercholesterolemia using integrated gene co-expression network analysis
Abstract
Familial hypercholesterolemia (FH) is a monogenic lipid disorder which promotes atherosclerosis and cardiovascular diseases. Owing to the lack of sufficient published information, this study aims to identify the potential genetic biomarkers for FH by studying the global gene expression profile of blood cells. The microarray expression data of FH patients and controls was analyzed by different computational biology methods like differential expression analysis, protein network mapping, hub gene identification, functional enrichment of biological pathways, and immune cell restriction analysis. Our results showed the dysregulated expression of 115 genes connected to lipid homeostasis, immune responses, cell adhesion molecules, canonical Wnt signaling, mucin type O-glycan biosynthesis pathways in FH patients. The findings from expanded protein interaction network construction with known FH genes and subsequent Gene Ontology (GO) annotations have also supported the above findings, in addition to identifying the involvement of dysregulated thyroid hormone and ErbB signaling pathways in FH patients. The genes like CSNK1A1, JAK3, PLCG2, RALA, and ZEB2 were found to be enriched under all GO annotation categories. The subsequent phenotype ontology results have revealed JAK3I, PLCG2, and ZEB2 as key hub genes contributing to the inflammation underlying cardiovascular and immune response related phenotypes. Immune cell restriction findings show that above three genes are highly expressed by T-follicular helper CD4+ T cells, naïve B cells, and monocytes, respectively. These findings not only provide a theoretical basis to understand the role of immune dysregulations underlying the atherosclerosis among FH patients but may also pave the way to develop genomic medicine for cardiovascular diseases.
Keywords: DEGs; Familial hypercholesterolemia; Gene expression; Microarray; Network; PPI.
© 2022 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures






Similar articles
-
Analysis of Differentially Expressed Genes and Molecular Pathways in Familial Hypercholesterolemia Involved in Atherosclerosis: A Systematic and Bioinformatics Approach.Front Genet. 2020 Jul 15;11:734. doi: 10.3389/fgene.2020.00734. eCollection 2020. Front Genet. 2020. PMID: 32760426 Free PMC article.
-
Investigation of the underlying genes and mechanism of familial hypercholesterolemia through bioinformatics analysis.BMC Cardiovasc Disord. 2020 Sep 16;20(1):419. doi: 10.1186/s12872-020-01701-z. BMC Cardiovasc Disord. 2020. PMID: 32938406 Free PMC article.
-
Bioinformatics analyses of gene expression profile identify key genes and functional pathways involved in cutaneous lupus erythematosus.Clin Rheumatol. 2022 Feb;41(2):437-452. doi: 10.1007/s10067-021-05913-2. Epub 2021 Sep 23. Clin Rheumatol. 2022. PMID: 34553293
-
The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.Dan Med Bull. 2002 Nov;49(4):318-45. Dan Med Bull. 2002. PMID: 12553167 Review.
-
Polygenic contribution for familial hypercholesterolemia (FH).Curr Opin Lipidol. 2021 Dec 1;32(6):392-395. doi: 10.1097/MOL.0000000000000787. Curr Opin Lipidol. 2021. PMID: 34751168 Review.
Cited by
-
Artificial Intelligence in Cardiology and Atherosclerosis in the Context of Precision Medicine: A Scoping Review.Appl Bionics Biomech. 2024 Apr 30;2024:2991243. doi: 10.1155/2024/2991243. eCollection 2024. Appl Bionics Biomech. 2024. PMID: 38715681 Free PMC article.
-
Network pharmacology based anti-diabetic attributes of bioactive compounds from Ocimum gratissimum L. through computational approach.Saudi J Biol Sci. 2023 Sep;30(9):103766. doi: 10.1016/j.sjbs.2023.103766. Epub 2023 Aug 6. Saudi J Biol Sci. 2023. PMID: 37588570 Free PMC article.
-
Identification of Plasma Exosomes hsa_circ_0001360 and hsa_circ_0000038 as Key Biomarkers of Coronary Heart Disease.Cardiol Res Pract. 2024 Mar 26;2024:5557143. doi: 10.1155/2024/5557143. eCollection 2024. Cardiol Res Pract. 2024. PMID: 38566808 Free PMC article.
-
A computational framework for identifying cytoskeletal genes associated with age-related diseases.Sci Rep. 2025 Apr 26;15(1):14590. doi: 10.1038/s41598-025-97363-y. Sci Rep. 2025. PMID: 40287491 Free PMC article.
-
Exome Sequencing Identifies the Extremely Rare ITGAV and FN1 Variants in Early Onset Inflammatory Bowel Disease Patients.Front Pediatr. 2022 May 26;10:895074. doi: 10.3389/fped.2022.895074. eCollection 2022. Front Pediatr. 2022. PMID: 35692981 Free PMC article.
References
-
- Awan Z.A., Rashidi O.M., Al-Shehri B.A., Jamil K., Elango R., Al-Aama J.Y., Hegele R.A., Banaganapalli B., Shaik N.A. Saudi Familial Hypercholesterolemia Patients With Rare LDLR Stop Gain Variant Showed Variable Clinical Phenotype and Resistance to Multiple Drug Regimen. Front Med (Lausanne). 2021;8 doi: 10.3389/fmed.2021.694668. - DOI - PMC - PubMed
-
- Alhabib K.F., Al-Rasadi K., Almigbal T.H., Batais M.A., Al-Zakwani I., Al-Allaf F.A., Al-Waili K., Zadjali F., Alghamdi M., Alnouri F., Awan Z., Kinsara A.J., AlQudaimi A., Almahmeed W., Sabbour H., Traina M., Atallah B., Al-Jarallah M., AlSarraf A., AlSayed N., Amin H., Altaradi H., Cheng X. Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry. PLoS ONE. 2021;16(6):e0251560. - PMC - PubMed
-
- Fantus D., Awan Z., Seidah N.G., Genest J. Aortic calcification: Novel insights from familial hypercholesterolemia and potential role for the low-density lipoprotein receptor. Atherosclerosis. 2013;226(1):9–15. - PubMed
-
- Villa G., Wong B., Kutikova L., Ray K.K., Mata P., Bruckert E. Prediction of cardiovascular risk in patients with familial hypercholesterolaemia. Eur. Heart J. Qual. Care Clin. Outcomes. 2017;3(4):274–280. - PubMed
-
- Berberich A.J., Hegele R.A. The complex molecular genetics of familial hypercholesterolaemia. Nat. Rev. Cardiol. 2019;16(1):9–20. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous